Other
Net Change in Cash
ResMed Net Change in Cash increased by 632.8% to $243.44M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 40.7%, from $410.77M to $243.44M. Over 2 years (FY 2023 to FY 2025), Net Change in Cash shows an upward trend with a 360.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
18 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$19.13M | -$81.67M | $7.29M | -$66.55M | $46.04M | -$25.31M | -$3.00K | -$18.79M | $1.15M | $27.66M | $451.00K | $188.00M | $95.58M | $410.77M | $276.74M | $174.40M | $33.22M | $243.44M |
| QoQ Change | — | -327.0% | +108.9% | <-999% | +169.2% | -155.0% | +100.0% | <-999% | +106.1% | >999% | -98.4% | >999% | -49.2% | +329.7% | -32.6% | -37.0% | -81.0% | +632.8% |
| YoY Change | — | — | — | -247.9% | +156.4% | -447.0% | — | +71.8% | -97.5% | +209.3% | >999% | >999% | >999% | >999% | >999% | -7.2% | -65.2% | -40.7% |
Range-$81.67M – $410.77M
CAGR+81.9%
Avg YoY Growth>999%
Median YoY Growth+114.1%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is ResMed's net change in cash?
- ResMed (RMD) reported net change in cash of $243.44M in Q1 2026.
- How has ResMed's net change in cash changed year-over-year?
- ResMed's net change in cash decreased by 40.7% year-over-year, from $410.77M to $243.44M.
- What is the long-term trend for ResMed's net change in cash?
- Over 2 years (2023 to 2025), ResMed's net change in cash has grown at a 360.4% compound annual growth rate (CAGR), from -$45.82M to $971.09M.
- What does net change in cash mean?
- The total change in the company's cash position over the period.